Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2111]

Quality of life and cost advantages of metronomics and drug repurposing

Dr Lisa Hutchinson - Editor of Nature Reviews, London, UK

Quality of life and cost advantages of metronomics and drug repurposing ( Dr Lisa Hutchinson - Editor of Nature Reviews, London, UK )

Advances in multiple myeloma: Expert panel discussion

Prof Pieter Sonneveld; Prof Antonio Palumbo; Prof Marivi Mateos; Prof Meletios...

Advances in multiple myeloma: Expert panel discussion ( Prof Pieter Sonneveld; Prof Antonio Palumbo; Prof Marivi Mateos; Prof Meletios Dimopoulos )

Impact of biomarker-integrated approaches of targeted therapy for lung cancer...

Prof Waun Ki Hong - University of Texas MD Anderson Cancer Center, Houston, USA

Impact of biomarker-integrated approaches of targeted therapy for lung cancer elimination ( Prof Waun Ki Hong - University of Texas MD Anderson Cancer Center, Houston, USA )

Networking and collaborating across borders in sub-Saharan Africa

Dr Shubhra Ghosh - Project Director of Global Programs, MD Anderson Cancer...

Networking and collaborating across borders in sub-Saharan Africa ( Dr Shubhra Ghosh - Project Director of Global Programs, MD Anderson Cancer Centre, Houston, USA )

WIN consortium as a basis for forming cross-border collaborations for improving...

Dr Oliver Bogler - MD Anderson Cancer Center, Houston, USA

WIN consortium as a basis for forming cross-border collaborations for improving personalised medicine and palliative care ( Dr Oliver Bogler - MD Anderson Cancer Center, Houston, USA )

Systems medicine approach to optimise drugs and drug combinations for...

Dr Olli Kallioniemi - University of Helsinki, Helsinki, Finland

Systems medicine approach to optimise drugs and drug combinations for individual AML patients ( Dr Olli Kallioniemi - University of Helsinki, Helsinki, Finland )

Work of the WIN consortium and challenges of personalised cancer therapy

Prof John Mendelsohn - University of Texas MD Anderson Cancer Center, Houston...

Work of the WIN consortium and challenges of personalised cancer therapy ( Prof John Mendelsohn - University of Texas MD Anderson Cancer Center, Houston, USA )

Molecular investigations of immune cells and tumour environment: The ovarian...

Dr George Coukos - Ludwig Center for Cancer Research, Epalinges, Switzerland

Molecular investigations of immune cells and tumour environment: The ovarian cancer model ( Dr George Coukos - Ludwig Center for Cancer Research, Epalinges, Switzerland )

Cancer stem cells and malignant progression

Prof Rob Weinberg - Massachusetts Institute of Technology, Cambridge, USA

Cancer stem cells and malignant progression ( Prof Rob Weinberg - Massachusetts Institute of Technology, Cambridge, USA )

microRNA replacement in malignant pleural mesothelioma

Dr Glen Reid - The University of Sydney, Sydney, Australia

microRNA replacement in malignant pleural mesothelioma ( Dr Glen Reid - The University of Sydney, Sydney, Australia )

Personalised cancer medicine using the human protein atlas and affibodies

Prof Mathias Uhlén - Royal Institute of Technology (KTH), Stockholm, Sweden

Personalised cancer medicine using the human protein atlas and affibodies ( Prof Mathias Uhlén - Royal Institute of Technology (KTH), Stockholm, Sweden )

IDH1 mutation in haemato-oncology

Dr Christof von Kalle - German Cancer Research Center (DKFZ), Heidelberg...

IDH1 mutation in haemato-oncology ( Dr Christof von Kalle - German Cancer Research Center (DKFZ), Heidelberg, Germany )

More from ecancer